Dr. Rakesh Patel is Board-Certified in Internal Medicine and has over 13 years of experience in Endocrine practice, including more than 10 years of experience in clinical research. He has vast knowledge in the areas of Type 1 and Type 2 Diabetes. Dr. Patel is very involved in the entire patient care experience and works with his staff to provide the best outcomes possible for his patients. Dr. Patel leads The Endocrine and Psychiatry Center, a member of Privia Medical Group – Gulf Coast since 2016.
Privia Medical Group – Gulf Coast was formed in 2016, when seven independent practices came together to change healthcare to “what it ought to be”. Privia is one of the highest performing and fastest growing medical groups in the country. Privia Medical Group was built to empower independent physicians to succeed in the shift to value-based care.
Since inception, Privia Medical Group – Gulf Coast has expanded to more than 250 providers in over 60 locations.
Endocrine and Psychiatry Center is a proud member of Privia Medical Group since December 13,2016. The practice sees on average between 120-140 patients a day with approximately 8 providers. The practice specializes in the following services:
- managing patients with a diagnosis of menopause
- testosterone issues
- weight management
- thyroid management
- diabetes management
Contact & Locations
Endocrine and Psychiatry Center
9539 Huffmeister Road
Houston, Texas 77095
Capabilities & Features
Staff Training & Technology Capabilities
- Athena EMR
- The team is trained in modern privacy standards (HIPAA), Human Subject Protection and Good Clinical Practice.
- Wireless internet access is available. Information is also kept secure with Secure Socket Layer (SSL) data encryption, firewalls, secure servers (including 24/7 surveillance and biometric access), multifactor authentication, and other measures to ensure information is secure.
MEDICAL RESEARCH DEVICES & EQUIPMENT
Routine calibration and quality assurance testing conducted on equipment.
- EKG Machine
- DEXA Scanner
- Lab Facility
- 20 Freezer
- Ultrasound machine
- 10 exam rooms
- Dedicated Monitoring space
- Ample supply storage
- Secured IP Storage
- Able to utilize central IRBs
Active & Upcoming Trials
A blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease.
To demonstrate the non-inferiority of xxx dose 1 compared to glimepiride on HbA1c (glycosylated A1c) reduction in patients with T2D (type 2 diabetes) who have inadequate glycemic control with metformin.
To demonstrate the superiority of xxx versus placebo on hemoglobin A1c (HbA1c) reduction in patients with type 2 diabetes (T2D) who have inadequate glycemic control on a xxx with or without metformin.